(Q33380288)

English

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma (English)

1 reference

Europe PubMed Central

26 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Siew Wan Hee

6

0 references

author name string

Swan Swan Leong

1

1 reference

Europe PubMed Central

26 July 2017

Joseph Wee

2

1 reference

Europe PubMed Central

26 July 2017

Sandeep Rajan

3

1 reference

Europe PubMed Central

26 July 2017

Chee Keong Toh

4

1 reference

Europe PubMed Central

26 July 2017

Wan Teck Lim

5

1 reference

Europe PubMed Central

26 July 2017

Miah Hiang Tay

7

1 reference

Europe PubMed Central

26 July 2017

Donald Poon

8

1 reference

Europe PubMed Central

26 July 2017

Eng Huat Tan

9

1 reference

Europe PubMed Central

26 July 2017

language of work or name

0 references

publication date

1 September 2008

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

113

1 reference

Europe PubMed Central

26 July 2017

6

1 reference

Europe PubMed Central

26 July 2017

1332-1337

1 reference

Europe PubMed Central

26 July 2017

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic varie

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of 5-fluorouracil and cisplatinum in recurrent or metastatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Triplet combination of gemcitabine, carboplatin, and paclitaxel in previously treated, relapsed ovarian and peritoneal carcinoma: an experience in Taiwan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma: a Phase II trial using a triplet combination.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Experience in a UK cancer centre of weekly paclitaxel in the treatment of relapsed ovarian and primary peritoneal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, Phase III Study of Weekly Paclitaxel in Combination With Carboplatin Versus Standard Every-3-Weeks Administration of Carboplatin and Paclitaxel for Patients With Previously Untreated Advanced Non–Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

One-sample multiple testing procedure for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of outpatient chemotherapy with cisplatin, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23687

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23687

1 reference

Europe PubMed Central

26 July 2017

1 reference

Europe PubMed Central

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33380288&oldid=1584709723"